review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1004939850 |
P356 | DOI | 10.1186/S12916-014-0130-5 |
P932 | PMC publication ID | 4226863 |
P698 | PubMed publication ID | 25385322 |
P5875 | ResearchGate publication ID | 268234366 |
P50 | author | M. Arfan Ikram | Q31229076 |
P2093 | author name string | Renée F A G de Bruijn | |
P2860 | cites work | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 |
Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment | Q26825570 | ||
The role of inflammasome in Alzheimer's disease | Q26996822 | ||
The pathobiology of vascular dementia | Q27006033 | ||
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease | Q46765734 | ||
Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study | Q46827141 | ||
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study | Q47240327 | ||
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study | Q47591273 | ||
Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population | Q48165634 | ||
Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial | Q48174837 | ||
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up. | Q48236842 | ||
Silent brain infarcts and the risk of dementia and cognitive decline | Q48353038 | ||
Atherosclerotic calcification relates to cognitive function and to brain changes on magnetic resonance imaging | Q48546784 | ||
Thyroid hormones, dementia, and atrophy of the medial temporal lobe | Q48569528 | ||
Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10-year follow-up. | Q48714201 | ||
Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. | Q48736131 | ||
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. | Q48856161 | ||
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. | Q48937145 | ||
Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. | Q49024974 | ||
Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. | Q49117935 | ||
Microvascular network alterations in the retina of patients with Alzheimer's disease. | Q50864313 | ||
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. | Q50972617 | ||
Incident lacunes influence cognitive decline: the LADIS study. | Q51010249 | ||
Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. | Q51015760 | ||
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. | Q51896138 | ||
Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. | Q51917859 | ||
Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. | Q51926808 | ||
Cerebral white matter lesions and the risk of dementia. | Q51936633 | ||
Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. | Q51950050 | ||
Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. | Q51969591 | ||
Midlife blood pressure and dementia: the Honolulu-Asia aging study. | Q53234678 | ||
Untangling vascular dementia. | Q53246011 | ||
Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. | Q53272112 | ||
Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. | Q53326227 | ||
Elevated plasma homocysteine level is not primarily related to Alzheimer's disease. | Q53333126 | ||
Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort. | Q53342942 | ||
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. | Q53375110 | ||
Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease. | Q53395047 | ||
Stroke and Alzheimer disease: fellow travelers or partners in crime? | Q53425826 | ||
Alzheimer's disease | Q55880664 | ||
Unrecognized Myocardial Infarction in Relation to Risk of Dementia and Cerebral Small Vessel Disease | Q57621288 | ||
Arterial Stiffness, Cognitive Decline, and Risk of Dementia | Q57781889 | ||
Atherosclerosis and risk for dementia | Q57781893 | ||
Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study | Q57781910 | ||
Lipoprotein-associated phospholipase A2 is associated with risk of dementia | Q57781951 | ||
The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions | Q57782031 | ||
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study | Q57782109 | ||
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study | Q57782154 | ||
A meta-analysis of physical activity in the prevention of coronary heart disease | Q68428351 | ||
Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study | Q71730400 | ||
The effect of borderline diabetes on the risk of dementia and Alzheimer's disease | Q40256860 | ||
Cerebrovascular pathology in Alzheimer's disease: cause, effect or epiphenomenon? | Q41611015 | ||
Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life | Q41759317 | ||
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition | Q43275099 | ||
Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. | Q43849688 | ||
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study | Q43935519 | ||
Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. | Q44022561 | ||
Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease | Q44033924 | ||
Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease | Q44206000 | ||
Homocysteine and brain atrophy on MRI of non-demented elderly | Q44246021 | ||
The association between physical activity and dementia in an elderly population: the Rotterdam Study | Q44312105 | ||
Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia | Q44681950 | ||
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study | Q44723607 | ||
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study | Q44779259 | ||
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease | Q45126159 | ||
Midlife cardiovascular risk factors and risk of dementia in late life | Q45236740 | ||
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study | Q45338572 | ||
Retinal vascular calibers associate differentially with cerebral gray matter and white matter atrophy | Q45421302 | ||
Subcortical connectivity in dementia with Lewy bodies and Alzheimer's disease | Q45820365 | ||
Chronic kidney disease: a risk factor for dementia onset: a population-based study. The Osaki-Tajiri Project. | Q45827024 | ||
Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment | Q46454611 | ||
White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers. | Q46523461 | ||
Controversies in stable coronary artery disease | Q28194400 | ||
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies | Q28306571 | ||
Running enhances neurogenesis, learning, and long-term potentiation in mice | Q29391363 | ||
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI | Q29619152 | ||
Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology | Q30434143 | ||
Resting state functional connectivity in preclinical Alzheimer's disease | Q30531401 | ||
Longitudinal effects of a decade of aging on carotid artery stiffness: the multiethnic study of atherosclerosis | Q30564047 | ||
Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics | Q30908064 | ||
Change in body mass index before and after Alzheimer's disease onset | Q33632560 | ||
Associations between serum cholesterol levels and cerebral amyloidosis | Q33853002 | ||
Coronary heart disease is associated with non-amnestic mild cognitive impairment | Q33926616 | ||
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease | Q33957399 | ||
Cardiac index is associated with brain aging: the Framingham Heart Study | Q34090309 | ||
Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus | Q34118784 | ||
Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study | Q34192778 | ||
Adherence to a Mediterranean diet and survival in a Greek population | Q34208988 | ||
Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis | Q34255325 | ||
Physical activity in middle-age and dementia in later life: findings from a prospective cohort of men in Caerphilly, South Wales and a meta-analysis | Q34278089 | ||
Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis | Q34380576 | ||
Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan | Q34423751 | ||
Poststroke dementia. | Q34461454 | ||
Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review | Q34554320 | ||
Retinal vascular caliber and risk of dementia: the Rotterdam study | Q34647063 | ||
Promising strategies for the prevention of dementia | Q34659276 | ||
Midlife overweight and obesity increase late-life dementia risk: a population-based twin study | Q34999328 | ||
Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study | Q35138401 | ||
Cerebrovascular lesions induce transient β-amyloid deposition | Q35606745 | ||
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus | Q35720477 | ||
Total daily physical activity and the risk of AD and cognitive decline in older adults. | Q35909823 | ||
Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy | Q36136280 | ||
The age-dependent relation of blood pressure to cognitive function and dementia | Q36201875 | ||
AD brain pathology: vascular origins? Results from the HAAS autopsy study | Q36219411 | ||
Memory after silent stroke: hippocampus and infarcts both matter | Q36304071 | ||
Risk of dementia in diabetes mellitus: a systematic review | Q36345254 | ||
Carotid atherosclerosis and prospective risk of dementia | Q36428795 | ||
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia | Q36455581 | ||
In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI | Q36655420 | ||
Aortic stiffness, blood pressure progression, and incident hypertension | Q36675855 | ||
Heart disease as a risk factor for dementia | Q36811092 | ||
Vascular risk factors, cognitive decline, and dementia | Q36812802 | ||
Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort | Q37027158 | ||
Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults | Q37067122 | ||
Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study | Q37124508 | ||
Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis | Q37151717 | ||
Cognition in older women: the importance of daytime movement | Q37187569 | ||
Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence | Q37197121 | ||
Effect of infarcts on dementia in the Baltimore longitudinal study of aging | Q37221901 | ||
Thyroid function and the risk of Alzheimer disease: the Framingham Study | Q37223038 | ||
Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? | Q37285389 | ||
Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study | Q37309799 | ||
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. | Q37366280 | ||
Physical activity, diet, and risk of Alzheimer disease | Q37394712 | ||
Thyroid function and Alzheimer's disease | Q37411924 | ||
White matter lesions on brain magnetic resonance imaging scan and 5-year cognitive decline: the Honolulu-Asia aging study | Q37545926 | ||
Activity energy expenditure and incident cognitive impairment in older adults | Q37582158 | ||
Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease | Q37622314 | ||
Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort | Q37709616 | ||
Vascular risk factor detection and control may prevent Alzheimer's disease | Q37729423 | ||
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. | Q37790861 | ||
Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis | Q37850632 | ||
Microembolism, silent brain infarcts and dementia | Q37994901 | ||
The dementia of cardiac disease | Q38042547 | ||
Cognitive disorders and dementia in CKD: the neglected kidney-brain axis | Q38071864 | ||
Increased number of microinfarcts in Alzheimer disease at 7-T MR imaging | Q38136868 | ||
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease | Q38188178 | ||
Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. | Q38189769 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
cardiovascular disease | Q389735 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 130 | |
P577 | publication date | 2014-11-11 | |
P1433 | published in | BMC Medicine | Q4835947 |
P1476 | title | Cardiovascular risk factors and future risk of Alzheimer's disease | |
P478 | volume | 12 |
Q37633191 | A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile |
Q98665295 | A population-based phenome-wide association study of cardiac and aortic structure and function |
Q36014564 | APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases |
Q95857189 | Alzheimer's Disease and Cardiovascular Disease: A Particular Association |
Q58701393 | Association between white matter lesions and cerebral Aβ burden |
Q64104755 | Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer's disease |
Q41660607 | Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease |
Q38721238 | Brain function and structure and risk for incident diabetes: The Atherosclerosis Risk in Communities Study |
Q89304890 | Broadening the scope of epidemiologic dementia research |
Q90699692 | Canine Models of Inherited Musculoskeletal and Neurodegenerative Diseases |
Q49217446 | Cardiovascular Risk Factors Are Correlated with Low Cognitive Function among Older Adults Across Europe Based on The SHARE Database. |
Q91271071 | Cardiovascular diseases and related risk factors accelerated cognitive deterioration in patients with late-life depression: a one-year prospective study |
Q39410816 | Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review. |
Q47949390 | Cerebrovascular abnormalities in Alzheimer's dementia: a more tractable treatment target? |
Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
Q55440462 | Conditions Associated with Essential Tremor in Veterans: A Potential Role for Chronic Stress. |
Q90061960 | Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty |
Q49962264 | Determinants, Prevalence, and Trajectory of Long-Term Post-Stroke Cognitive Impairment: Results from a 4-Year Follow-Up of the ARCOS-IV Study. |
Q52092503 | Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention? |
Q37530095 | Differential burden of rare protein truncating variants in Alzheimer's disease patients compared to centenarians. |
Q38756224 | Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms. |
Q33749531 | Emerging Evidence on Neutrophil Motility Supporting Its Usefulness to Define Vitamin C Intake Requirements |
Q55208569 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? |
Q57071918 | European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? |
Q39931876 | Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics |
Q35658728 | Gout and the risk of dementia: a nationwide population-based cohort study |
Q92843677 | HDL from an Alzheimer's disease perspective |
Q57300033 | HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β-Microglobulin a Missing Piece of the Pathogenetic Puzzle? |
Q36198753 | Human gut microbiota: the links with dementia development |
Q57181162 | Hypertension, dietary salt and cognitive impairment |
Q54974138 | Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology? |
Q92126818 | Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer's Disease |
Q47789561 | Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment |
Q42374740 | Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group |
Q89441161 | Klotho at the Edge of Alzheimer's Disease and Senile Depression |
Q33787909 | Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment |
Q60046576 | Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding |
Q92332262 | Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study |
Q37562875 | Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors |
Q48514781 | Mixed dementia: A review of the evidence |
Q36951659 | Nationwide Inpatient Prevalence, Predictors, and Outcomes of Alzheimer's Disease among Older Adults in the United States, 2002-2012 |
Q38663632 | Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies |
Q38619805 | New approach to generating insights for aging research based on literature mining and knowledge integration |
Q38297016 | Pathogenesis and treatment of vascular cognitive impairment |
Q47682467 | Physical Activity in Preventing Alzheimer's Disease and Cognitive Decline: A Narrative Review |
Q28068353 | Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease |
Q38785485 | Reduced Cardiovascular Functions in Patients with Alzheimer's Disease |
Q30831782 | Reducing dementia risk by targeting modifiable risk factors in mid-life: study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trial |
Q35925677 | Relationship between the gene polymorphisms of kallikrein-kinin system and Alzheimer's disease in a Hunan Han Chinese population |
Q64991347 | Relative risk for Alzheimer disease based on complete family history. |
Q64062230 | Risk of dementia in patients with end-stage renal disease under maintenance dialysis-a nationwide population-based study with consideration of competing risk of mortality |
Q91706991 | Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks |
Q57159582 | Shared Biological Pathways Between Alzheimer's Disease and Ischemic Stroke |
Q64260844 | Smoking and Obesity as Risk Factors in Frontotemporal Dementia and Alzheimer's Disease: The HUNT Study |
Q37424595 | Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts |
Q34541613 | Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies. |
Q47233523 | Tau Proteins and Tauopathies in Alzheimer's Disease |
Q38705144 | The Association between the Mediterranean Dietary Pattern and Cognitive Health: A Systematic Review. |
Q55002611 | The Dose-Dependent Effects of Vascular Risk Factors on Dynamic Compensatory Neural Processes in Mild Cognitive Impairment. |
Q54314640 | The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease. |
Q37423159 | The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease |
Q36084114 | The Rotterdam Study: 2016 objectives and design update |
Q57177786 | The cholinergic system in the pathophysiology and treatment of Alzheimer's disease |
Q90348245 | The factors contributing to cognitive dysfunction in type 2 diabetic patients |
Q38969718 | The impact of cerebrovascular aging on vascular cognitive impairment and dementia. |
Q26740007 | Therapies for Prevention and Treatment of Alzheimer's Disease |
Q97652836 | Tinnitus and risk of Alzheimer's and Parkinson's disease: a retrospective nationwide population-based cohort study |
Q47673606 | Undetected Peripheral Arterial Disease Among Older Adults With Alzheimer's Disease and Other Dementias |
Q47907796 | Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population |
Q57813319 | Vascular dementia |
Q57813443 | Vascular risk factors and Alzheimer's disease |
Q96692382 | White matter lesions and temporal atrophy are associated with cognitive and neuropsychiatric symptoms in patients with hypertension and alzheimer´s disease |
Q55425958 | Wishes and preferences for an online lifestyle program for brain health-A mixed methods study. |
Q38782266 | mTOR drives cerebral blood flow and memory deficits in LDLR(-/-) mice modeling atherosclerosis and vascular cognitive impairment |
Search more.